Synta’s GSK Deal No Investor Surprise
By Business Review Editor
Pharma Deals Review: Vol 2007 Issue 89 (Table of Contents)
Published: 7 Nov-2007
DOI: 10.3833/pdr.v2007.i89.265 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
GlaxoSmithKline (GSK) has entered into a global alliance with Synta Pharmaceuticals to develop a drug, elesclomol (STA-4783) for the treatment of metastatic melanoma...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS